Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 23, 2021

SELL
$5.35 - $6.35 $1.67 Million - $1.99 Million
-312,906 Closed
0 $0
Q1 2021

Apr 27, 2021

SELL
$5.68 - $7.87 $109,050 - $151,096
-19,199 Reduced 5.78%
312,906 $1.88 Million
Q4 2020

Feb 03, 2021

SELL
$5.25 - $8.56 $192,449 - $313,783
-36,657 Reduced 9.94%
332,105 $2.3 Million
Q3 2020

Oct 27, 2020

BUY
$5.78 - $7.47 $42,997 - $55,569
7,439 Added 2.06%
368,762 $2.31 Million
Q2 2020

Aug 04, 2020

SELL
$4.5 - $7.02 $668,367 - $1.04 Million
-148,526 Reduced 29.13%
361,323 $2.39 Million
Q4 2019

Jan 31, 2020

BUY
$3.84 - $4.86 $354,236 - $448,330
92,249 Added 22.09%
509,849 $2.15 Million
Q3 2019

Oct 23, 2019

BUY
$4.86 - $6.05 $2.03 Million - $2.53 Million
417,600 New
417,600 $2.15 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.